CDK4/6/1 Inhibitor

Modify Date: 2024-01-13 18:38:51

CDK4/6/1 Inhibitor Structure
CDK4/6/1 Inhibitor structure
Common Name CDK4/6/1 Inhibitor
CAS Number 2099128-41-1 Molecular Weight 488.57
Density N/A Boiling Point N/A
Molecular Formula C28H30F2N6 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CDK4/6/1 Inhibitor


CDK4/6/1 Inhibitor is a CDK4/6 inhibitor with IC50s of 3 and 1 nM, respectively.

 Names

Name CDK4/6/1 Inhibitor

 CDK4/6/1 Inhibitor Biological Activity

Description CDK4/6/1 Inhibitor is a CDK4/6 inhibitor with IC50s of 3 and 1 nM, respectively.
Related Catalog
Target

IC50: 3 nM (CDK4), 1 nM (CDK6)[1]

In Vitro CDK4/6/1 Inhibitor is a potent anti-proliferative agent that arrests U87MG cell line exclusively in G1 (IC50=15.3 ± 2.9 nM in the anti-proliferation assay). U87MG cells exposed to varying concentrations of CDK4/6/1 Inhibitor for 24 hours show a dose-related increase in G1 arrest, and a significant increase in the percentage of cells in G1 is found in as little as 13.72 nM of CDK4/6/1 Inhibitor[1].
In Vivo CDK4/6/1 Inhibitor has tumor growth inhibition values ranging from 62% to 99% for doses ranging from 3.125 to 50 mg/kg in an orthotopic xenograft mouse model of glioblastoma multiforme, and no significant body weight loss is observed. The increase in life span based on the median survival time of vehicle-treated animals in mice administered a dose of 50 mg/kg is significant at 162%[1].
Cell Assay The U87MG glioblastoma cells are treated with CDK4/6/1 and incubated for 72 h at 37°C. Then the medium is removed, 4% paraformaldehyde (50 µL/well) is added to the wells, and the cells are fixed for 30 min at RT. Cells are washed twice with phosphate-buffered saline (PBS) solution, and permeabilized in 0.2% Triton-X100 for 5 min. Cells are ished twice with PBS, after which 50 µL DAPI (1 µg/mL) is added to the wells, followed by incubation of the cells in the dark for 20 min. After ishing three times with PBS, PBS (100 µL/well) is added to the wells. The plates are scanned using IN Cell Analyzer 2200[1].
Animal Admin Mice[1] In the U87MG-Luc orthotopic xenograft mouse model, mice are treated with 3.125, 6.25, 12.5, 25, 50 mg/kg QD CDK4/6/1 Inhibitor for 28 days
References

[1]. Yin L, et al. A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy. Eur J Med Chem. 2018 Jan 20;144:1-28.

 Chemical & Physical Properties

Molecular Formula C28H30F2N6
Molecular Weight 488.57
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

CDK4/6/1 Inhibitor suppliers

CDK4/6/1 Inhibitor price